Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 18;58(12):e01926-19.
doi: 10.1128/JCM.01926-19. Print 2020 Nov 18.

Diagnostic Approach for Arboviral Infections in the United States

Affiliations
Review

Diagnostic Approach for Arboviral Infections in the United States

Anne Piantadosi et al. J Clin Microbiol. .

Abstract

Domestic arthropod-borne viruses (arboviruses) are single-stranded RNA viruses, the most common of which include the mosquito-borne West Nile virus, St. Louis encephalitis virus, La Crosse virus, Jamestown Canyon virus, and eastern equine encephalitis virus, as well as the tick-borne Powassan virus. Previously considered rare infections, they have been detected with increasing frequency over the past 2 decades. Here, we present an overview of the domestic arboviruses listed above and describe the modalities employed to diagnose infection. Global arboviruses, including dengue virus, Zika virus, and chikungunya virus, have also been increasingly detected in the United States within the last 5 years but are not a focus of this minireview. Typical manifestations of arbovirus infection range from no symptoms, to meningitis or encephalitis, to death. Serologies are the standard means of diagnosis in the laboratory, since most viruses have a short period of replication, limiting the utility of molecular tests. The interpretation of serologies is confounded by antibody cross-reactivity with viruses belonging to the same serogroup and by long-lasting antibodies from prior infections. Next-generation assays have improved performance by increasing antigen purity, selecting optimal epitopes, and improving interpretive algorithms, but challenges remain. Due to cross-reactivity, a positive first-line serology test requires confirmation by either a plaque reduction neutralization test or detection of seroconversion or a 4-fold rise in virus-specific IgM or IgG antibody titers from acute- and convalescent-phase sera. The use of molecular diagnostics, such as reverse transcription PCR or unbiased metagenomic sequencing, is limited to the minority of patients who present with ongoing viremia or central nervous system replication. With the continued expansion of vector range, the diagnosis of domestic arboviruses will become an increasingly important task for generalists and specialists alike.

Keywords: Jamestown Canyon virus; La Crosse virus; Powassan virus; St. Louis encephalitis virus; West Nile virus; arbovirus; eastern equine encephalitis virus; encephalitis.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Geographic distribution of the most common domestic arboviruses: WNV (A), other flaviviruses POWV and SLEV (B), bunyaviruses LACV and JCV (C), and alphavirus EEE (D). Maps reflect the total number of neuroinvasive cases reported from 2014 to 2018 (2, 89–92). (The maps were created with mapchart.net.)
FIG 2
FIG 2
Pathways to diagnose probable and confirmed arbovirus infection. For patients with suspected active viral replication, the direct detection of pathogen nucleic acid in serum or affected tissue or growth of virus in culture confirms diagnosis. Most patients present after the period of viremia, thereby requiring the use of serologies. A positive IgM ELISA from serum or CSF establishes a probable diagnosis. Confirmation of disease requires detection of serum-neutralizing antibodies, seroconversion, or a 4-fold increase in either IgM or IgG titers from paired sera. Neuroinvasive disease can be confirmed by the same methods or by negative CSF IgM ELISA testing against other endemic arboviruses that circulate in the same geographic area.

References

    1. Lindsey NP, Staples JE, Lehman JA, Fischer M, Centers for Disease Control and Prevention (CDC). 2010. Surveillance for human West Nile virus disease—United States, 1999–2008. MMWR Surveill Summ 59:1–17. - PubMed
    1. McDonald E, Martin SW, Landry K, Gould CV, Lehman J, Fischer M, Lindsey NP. 2019. West Nile virus and other domestic nationally notifiable arboviral diseases—United States, 2018. MMWR Morb Mortal Wkly Rep 68:673–678. doi:10.15585/mmwr.mm6831a1. - DOI - PMC - PubMed
    1. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290:511–515. doi:10.1001/jama.290.4.511. - DOI - PubMed
    1. Piantadosi A, Rubin DB, McQuillen DP, Hsu L, Lederer PA, Ashbaugh CD, Duffalo C, Duncan R, Thon J, Bhattacharyya S, Basgoz N, Feske SK, Lyons JL. 2016. Emerging cases of Powassan virus encephalitis in New England: clinical presentation, imaging, and review of the literature. Clin Infect Dis 62:707–713. doi:10.1093/cid/civ1005. - DOI - PMC - PubMed
    1. Kinsella CM, Paras ML, Smole S, Mehta S, Ganesh V, Chen LH, McQuillen DP, Shah R, Chan J, Osborne M, Hennigan S, Halpern-Smith F, Brown CM, Sabeti P, Piantadosi A. 2020. Jamestown Canyon virus in Massachusetts: clinical case series and vector screening. Emerg Microbes Infect 9:903–912. doi:10.1080/22221751.2020.1756697. - DOI - PMC - PubMed